HAVN Life Sciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; HAVN Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22
Income Statement	-
Total Revenue	$ 57.92K	$ 629.49K	$ 135.82K	$ 479.19K	$ 284.81K
Gross Profit	$ -13.35K	$ 403.66K	$ 44.06K	$ 155.95K	$ 267.64K
EBIT	$ -665.73K	$ -4.96M	$ -7.78M	$ -34.50M	$ -563.47K
EBITDA	$ -687.72K	$ -5.00M	$ -7.69M	$ -34.16M	$ -431.43K
Net Income Common Stockholders	$ -665.73K	$ -4.96M	$ -7.81M	$ -34.59M	$ -563.47K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 13.99K	$ 17.26K	$ 224.84K	$ 2.11M	$ 1.69M
Total Assets	$ 11.11M	$ 3.22M	$ 401.63K	$ 8.12M	$ 26.94M
Total Debt	$ ―	$ ―	$ ―	$ 778.71K	$ 814.09K
Net Debt	$ ―	$ ―	$ ―	$ -1.33M	$ -875.63K
Total Liabilities	$ 540.44K	$ 1.35M	$ 2.19M	$ 1.84M	$ 1.82M
Stockholders Equity	$ 837.82K	$ 1.88M	$ ―	$ 6.28M	$ 25.12M
Cash Flow	-
Free Cash Flow	$ 1.74M	$ -1.12M	$ -1.78M	$ -2.84M	$ -1.46M
Operating Cash Flow	$ 1.74M	$ -1.12M	$ -1.78M	$ -2.90M	$ -1.45M
Investing Cash Flow	-	-	-	$ 56.00K	$ -16.96K
Financing Cash Flow	$ -685.29K	$ 908.52K	$ -105.47K	$ 3.27M	$ -32.74K

Currency in USD

HAVN Life Sciences Earnings and Revenue History

Income Statement >

HAVN Life Sciences Debt to Assets

Balance Sheet >

HAVN Life Sciences Cash Flow

Cash Flow >

HAVN Life Sciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing